Interleukin (IL)-25 suppresses IL-22-induced osteoclastogenesis in rheumatoid arthritis via STAT3 and p38 MAPK/IκBα pathway

Interleukin (IL)-25 suppresses IL-22-induced osteoclastogenesis in rheumatoid arthritis via STAT3 and p38 MAPK/IκBα pathway

Abstract Background The present study aimed to evaluate the suppressive role of interleukin (IL)-25 in IL-22-induced osteoclastogenesis and receptor activator of nuclear factor κB ligand (RANKL) expression in rheumatoid arthritis (RA). Methods Serum from patients with RA and osteoarthritis (OA), and...

Full description

Bibliographic Details
Main Authors: Hong Ki Min, Ji-Yeon Won, Bo-Mi Kim, Kyung-Ann Lee, Seoung-Joon Lee, Sang-Heon Lee, Hae-Rim Kim, Kyoung-Woon Kim
Format: Article
Language:English
Published: BMC 2020-09-01
Series:Arthritis Research & Therapy
Subjects:
Rheumatoid arthritis
Osteoclastogenesis
IL-22
IL-25
Online Access:http://link.springer.com/article/10.1186/s13075-020-02315-8

Internet

http://link.springer.com/article/10.1186/s13075-020-02315-8

Similar Items